The possibility that co-occurring alterations of RTK/ligand pairs or TKs and EMT TAs detected in tumor/liquid biopsies, plasma DNA or exosomes from BCa patients might predict clinical outcome warrants further study. This evidence concerns the gene CDC42 and neoplasm.